SAB-Y9-59

N/A

Report date: 2025/01/26 17:50:55

Base Information

Drug NameSAB-Y9-59

Drug Alias NameSAB-Y9-59

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionEphrin type-A receptor 2 modulatorsIntegrin modulators

TargetsIntegrinEphrin type-A receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSyntab Therapeutics Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesSyntab Therapeutics Gmbh

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A